NIH-funded research R03 grant

Understanding how pancreatic beta cells grow and multiply

Official title: Metabolic requirements of pancreatic beta cell proliferation

Funded at University of Colorado Denver · NIH-11226108 · Data updated 2026-11-12

This study is looking at how certain processes in your body help pancreatic beta cells, which make insulin, grow and multiply, especially in people with Type 1 diabetes, to find new ways to help these cells regenerate and improve blood sugar control.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startMay 1, 2023
Project endApril 30, 2026
Funding year2024
Award (this year)$107,765
NIH project number7R03DK135459-03
Project IDNIH-11226108 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Type 1 diabetes who may benefit from therapies aimed at increasing beta cell proliferation.

Less likely to help

Patients with Type 2 diabetes or those whose diabetes is not related to beta cell loss may not receive benefits from this research.

What this research studies

This research investigates the metabolic processes that support the growth and replication of pancreatic beta cells, which are crucial for insulin production. By focusing on the enzyme ATP-citrate lyase, the study aims to identify metabolic bottlenecks that limit the proliferation of these cells in the context of Type 1 diabetes. The approach combines insights from cellular metabolism and epigenetics to explore new therapeutic strategies that could enhance beta cell regeneration. Patients may benefit from potential treatments that could restore insulin production and improve blood glucose control.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that enhance the regeneration of insulin-producing beta cells, potentially reducing the need for insulin therapy in Type 1 diabetes patients.

How similar studies have gone: While there has been substantial preclinical development in therapies for beta cell regeneration, this specific approach focusing on metabolic pathways is relatively novel and has not been extensively tested in clinical settings.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Wortham, Matthew — University of Colorado Denver
  • Study coordinator: Wortham, Matthew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.